HI
CRBP icon

Harbour Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

Harbour Investments’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122 Buy
+13
New +$109 ﹤0.01% 4489
2021
Q4 		– Sell
-80
Closed -$2K – 2833
2021
Q3 		$2K Hold
80
– – ﹤0.01% 3281
2021
Q2 		$4K Buy
80
+33
+70% +$1.83K ﹤0.01% 3128
2021
Q1 		$3K Buy
+47
New +$3.09K ﹤0.01% 3073

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harbour Investments's CRBP Position: Q1 2026 in Review

Harbour Investments opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 13 shares worth $122. The stake represents ﹤0.01% of the portfolio and ranks #4489 among its holdings. This is a return to the name: Harbour Investments previously reported a position in CRBP as recently as Q3 2021.

Harbour Investments first reported a position in CRBP in Q1 2021 and has held it in 4 quarters since. The position peaked at $4K in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Harbour Investments held 13 shares of Corbus Pharmaceuticals worth $122 as of Q1 2026.
  • Corbus Pharmaceuticals was a new Harbour Investments position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4489 holding.
  • Harbour Investments first reported a position in Corbus Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Harbour Investments's Corbus Pharmaceuticals position peaked at $4K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.